The Impact of the Use of the MAURISSE Application in People Suffering From an Addiction.

Launched by UNIVERSITY HOSPITAL, TOULOUSE · Jul 18, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the use of a mobile application called MAURISSE, which aims to strengthen the relationship between patients dealing with substance use disorders and their healthcare providers. The goal is to see if using this app helps patients feel more engaged in their treatment and builds trust with their care team. This is important because many patients with substance use disorders struggle with trusting healthcare providers, which can make it harder for them to stay on track with their recovery.

To participate in this trial, individuals need to be over 18 years old and starting specialized treatment for addiction, whether it’s related to substances like drugs or alcohol, or behavioral addictions like gambling. They should have a smartphone and internet access, and be able to read and understand French. Participants will be asked to give their consent to join the study. If accepted, they can expect to use the MAURISSE app as part of their treatment, which may help improve their support and engagement with their healthcare team. The study is currently recruiting participants, so there’s an opportunity to get involved in this innovative approach to addiction treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient over 18 years old,
• • Starting specialized treatment for addiction (addiction to substance and behavioral addiction too as money games addiction).
• • Suffering from any type of addiction, with an active addiction requiring weekly monitoring of substance use.
• • possessing a smartphone or having access to a smartphone and having access to an internet connection.
• • Able to read and understand French.
• • Affiliated or beneficiary of a social security scheme.
• • Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research).
• Exclusion Criteria:
• • Patient with cognitive or psychiatric disorders that may affect their ability to consent.
• • Participation in another protocol involving a modification of the treatment for addiction.
• • Known or suspected pregnancy.
• • Person under legal protection.